Key result
VExUS score correlates strongly with invasively measured right atrial pressure in CICU patients.
Why the study?
The Venous Excess Ultrasound Score (VExUS) provides a noninvasive assessment of systemic venous congestion, but its physiological correlates in the cardiac intensive care unit (CICU) remain incompletely characterized in patients with acute heart failure and cardiogenic shock.
Does the Venous Excess Ultrasound Score (VExUS) correlate with invasively measured right atrial pressure and identify hepato–renal organ dysfunction in patients admitted to the CICU with acute heart failure or cardiogenic shock?
Cohort (n=94)
Open-label
No
Does the Venous Excess Ultrasound Score (VExUS) correlate with invasively measured right atrial pressure and identify hepato–renal organ dysfunction in patients admitted to the CICU with acute heart failure or cardiogenic shock?
Effect estimate: ρ = 0.67
Absolute Event Rate: 15% vs 9%
p-value: p=<0.001
In CICU patients with acute heart failure or cardiogenic shock, the noninvasive VExUS score strongly correlates with invasive right atrial pressure and identifies downstream hepato–renal organ dysfunction beyond right atrial pressure alone.
VExUS may aid noninvasive RAP estimation in AHF/CS; hypothesis-generating for decongestion guidance pending prospective validation.
Venous congestion is a major determinant of organ dysfunction in acute heart failure (AHF) and cardiogenic shock (CS). The Venous Excess Ultrasound Score (VExUS) provides a noninvasive assessment of systemic venous congestion, but its physiological correlates in the cardiac intensive care unit (CICU) remain incompletely characterized. In this prospective single-center study, 94 patients with AHF or CS underwent simultaneous VExUS assessment and invasive right atrial pressure (RAP) measurement within 24 h of CICU admission. VExUS (graded 0–3; Low 0–1 vs High 2–3) was evaluated for correlation with RAP and associations with hemodynamic, echocardiographic, and organ dysfunction indices. Prespecified RAP–VExUS phenotypes (RAP ≤ 10 vs > 10 mmHg; Low vs High VExUS) were used to assess differences in hepato–renal biochemical markers, with adjustment for relevant clinical and hemodynamic covariates. In-hospital mortality was explored using univariate logistic regression. High VExUS was present in 29 patients (31%). VExUS correlated with RAP (ρ = 0.67), inversely with the MAP–RAP gradient, and was associated with impaired right ventricular function and greater hepato–renal biochemical abnormalities, but not with lactate or urine output. RAP–VExUS discordance occurred in 30.9% of patients. Among patients with elevated RAP (> 10 mmHg), those with High VExUS showed greater hepato–renal biochemical dysfunction than those with Low VExUS ( p < 0.01). The incremental contribution of VExUS beyond RAP was mainly evident for bilirubin. In-hospital mortality was numerically higher in High versus Low VExUS patients, without reaching statistical significance (24% vs. 15%, p = 0.39). In patients with acute heart failure or cardiogenic shock, VExUS was associated with invasively measured RAP and hepato–renal biochemical abnormalities, suggesting a complementary role in congestion phenotyping alongside invasive hemodynamic assessment.
No takes yet. Share an insight, caveat, or question.
Filomia et al. (2026) conducted a cohort in Acute heart failure or cardiogenic shock (n=94). High Venous Excess Ultrasound Score (VExUS grade 2-3) vs. Low Venous Excess Ultrasound Score (VExUS grade 0-1) was evaluated on Invasively measured right atrial pressure (RAP, mmHg) and Spearman correlation with VExUS grade (0-3) (ρ = 0.67, p=<0.001). The Venous Excess Ultrasound Score (VExUS) correlated strongly with invasively measured right atrial pressure (ρ = 0.67, p < 0.001) and hepato-renal dysfunction in CICU patients with AHF or CS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: